Key Principles for Conducting a Good Randomized Controlled Trial

References

1. 1.↵
   1. Beran A,
   2. Srour O,
   3. Malhas SE,
   4. Mhanna M,
   5. Ayesh H,
   6. Sajdeya O,
   7. et al

   . High-flow nasal cannula versus noninvasive ventilation in patients with COVID-19. Respir Care 2022;67(9):1177-1189.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Grieco DL,
   2. Menga LS,
   3. Cesarano M,
   4. Rosà T,
   5. Spadaro S,
   6. Bitondo MM,
   7. et al

   ; COVID-ICU Gemelli Study Group. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA 2021;325(17):1731-1743.

   OpenUrlPubMed
3. 3.↵
   1. Nair PR,
   2. Haritha D,
   3. Behera S,
   4. Kayina CA,
   5. Maitra S,
   6. Anand RK,
   7. et al

   . Comparison of high-flow nasal cannula and noninvasive ventilation in acute hypoxemic respiratory failure due to severe COVID-19 pneumonia. Respir Care 2021;66(12):1824-1830.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Murad MH,
   2. Asi N,
   3. Alsawas M,
   4. Alahdab F

   . New evidence pyramid. Evid Based Med 2016;21(4):125-127.

   OpenUrlPubMed
5. 5.↵
   1. Tomlin G,
   2. Borgetto B

   . Research pyramid: a new evidence-based practice model for occupational therapy. Am J Occup Ther 2011;65(2):189-196.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bellomo R,
   2. Warrillow SJ,
   3. Reade MC

   . Why we should be wary of single-center trials. Crit Care Med 2009;37(12):3114-3119.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Bafeta A,
   2. Dechartres A,
   3. Trinquart L,
   4. Yavchitz A,
   5. Boutron I,
   6. Ravaud P

   . Impact of single-center status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ 2012;344:e813.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Berelowitz KS,
   2. Wolf C,
   3. Täubel J

   . Benefits of a single- versus multi-center approach in early-phase patient studies a case study of multiple sclerosis patients. New Horiz Clin Res 2011;25:21-25.

   OpenUrl
9. 9.↵
   1. Chan AW,
   2. Altman DG

   . Identifying outcome reporting bias in randomized trials on PubMed: review of publications and survey of authors. BMJ 2005;330(7494):753.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Chan AW,
    2. Krleza-Jerić K,
    3. Schmid I,
    4. Altman DG

    . Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171(7):735-740.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Schulz KF,
    2. Altman DG,
    3. Moher D

    ; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ 2010;340:c332.

    OpenUrlFREE Full Text
12. 12.↵
    1. Moher D,
    2. Schulz KF,
    3. Altman DG

    . The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001;357(9263):1191-1194.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Turner L,
    2. Moher D,
    3. Shamseer L,
    4. Weeks L,
    5. Peters J,
    6. Plint A,
    7. et al

    . The influence of CONSORT on the quality of reporting of randomized controlled trials: an updated review. Trials 2011;12(S1)A47.
14. 14.↵
    1. De Angelis CD,
    2. Drazen JM,
    3. Frizelle FA,
    4. Haug C,
    5. Hoey J,
    6. Horton R,
    7. et al

    ; International Committee of Medical Journal Editors. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet 2005;365(9474):1827-1829.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Dickersin K,
    2. Rennie D

    . Registering clinical trials. JAMA 2003;290(4):516-523.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Zarin DA,
    2. Keselman A

    . Registering a clinical trial in ClinicalTrials.gov. Chest 2007;131(3):909-912.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Elliott TR

    . Registering randomized clinical trials and the case for CONSORT. Exp Clin Psychopharmacol 2007;15(6):511-518.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Speich B,
    2. Gloy VL,
    3. Klatte K,
    4. Gryaznov D,
    5. Taji Heravi A,
    6. Ghosh N,
    7. et al

    ; Adherence to Spirit Recommendations (ASPIRE) Study Group. Reliability of trial information across registries for trials with multiple registrations: a systematic review. JAMA Netw Open 2021;4(11):e2128898.

    OpenUrl
19. 19.↵
    1. Altman DG,
    2. Schulz KF

    . Statistics notes: concealing treatment allocation in randomized trials. BMJ 2001;323(7310):446-447.

    OpenUrlFREE Full Text
20. 20.↵
    1. Schulz KF,
    2. Chalmers I,
    3. Hayes RJ,
    4. Altman DG

    . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-412.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Moustgaard H,
    2. Clayton GL,
    3. Jones HE,
    4. Boutron I,
    5. Jørgensen L,
    6. Laursen DRT,
    7. et al

    . Impact of blinding on estimated treatment effects in randomized clinical trials: meta-epidemiological study. BMJ 2020;368:l6802.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Balk EM,
    2. Bonis PA,
    3. Moskowitz H,
    4. Schmid CH,
    5. Ioannidis JP,
    6. Wang C,
    7. et al

    . Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002;287(22):2973-2982.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Savović J,
    2. Jones HE,
    3. Altman DG,
    4. Harris RJ,
    5. Jüni P,
    6. Pildal J,
    7. et al

    . Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials. Ann Intern Med 2012;157(6):429-438.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Skelly AC,
    2. Dettori JR,
    3. Brodt ED

    . Assessing bias: the importance of considering confounding. Evid Based Spine Care J 2012;3(1):9-12.

    OpenUrlPubMed
25. 25.↵
    1. Roberts C,
    2. Torgerson DJ

    . Understanding controlled trials: baseline imbalance in randomzsed controlled trials. BMJ 1999;319(7203):185.

    OpenUrlFREE Full Text
26. 26.↵
    1. Li J,
    2. Luo J,
    3. Pavlov I,
    4. Perez Y,
    5. Tan W,
    6. Roca O,
    7. et al

    . Awake prone positioning for non-intubated patients with COVID-19–related acute hypoxemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med 2022;10(6):573-583.

    OpenUrl
27. 27.↵
    1. Jager KJ,
    2. Zoccali C,
    3. Macleod A,
    4. Dekker FW

    . Confounding: what it is and how to deal with it. Kidney Int 2008;73(3):256-260.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Fogel DB

    . Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun 2018;11:156-164.

    OpenUrlPubMed